[Lu-177]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

- Hofman, Michael S., Emmett, Louise, Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Weickhardt, Andrew, Scott, Andrew M., Lee, Sze-Ting, Kwan, Edmond M., Azad, Arun A., Ramdave, Shakher, Redfern, Andrew D., Sandhu, Shahneen, Macdonald, William, Guminski, Alex, Hsiao, Edward, Chua, Wei, Lin, Peter, Zhang, Alison Y., McJannett, Margaret M., Stockler, Martin R., Violet, John A., Williams, Scott G., Iravani, Amir, Martin, Andrew J., Davis, Ian D., Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Ng, Siobhan

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

- Kneebone, Andrew, Fraser-Browne, Carol, Duchesne, Gillian M., Fisher, Richard, Frydenberg, Mark, Herschtal, Alan, Williams, Scott G., Brown, Chris, Delprado, Waeick, Haworth, Annette, Joseph, David J., Martin, Jarad M., Matthews, John H. L., Millar, Jeremy L., Sidhom, Milllar, Spry, Nigel, Tang, Colin I., Turner, Sandra, Wiltshire, Kirsty L., Woo, Henry H., Davis, Ian D., Lim, Tee S., Pearse, Maria

Extracranial oligometastatic renal cell carcinoma: current management and future directions

- Loh, Jasmin, Davis, Ian D., Martin, Jarad M., Siva, Shankar

Mycoplasma infection alters cancer stem cell properties in vitro

- Gedye, Craig, Cardwell, Tracy, Hide, Winston, Caballero, Otavia, Davis, Ian D., Cebon, Jonathan, Dimopoulos, Nektaria, Tan, Bee Shin, Jackson, Heather, Svobodová, Suzanne, Anaka, Matthew, Behren, Andreas, Maher, Christopher, Hofmann, Oliver

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage i testicular cancer

- Grimison, Peter, Houghton, Baerin, Chatfield, Mark, Toner, Guy C., Davis, Ian D., Martin, Jarad, Hovey, Elizabeth, Stockler, Martin R.